Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus

Minea, Bogdan; Nastasa, Valentin; Kolecka, Anna; Mares, Magdalena; Marangoci, Narcisa; Roșca, Irina; Pinteală, Mariana; Hăncianu, Monica; Mareș, Mihai

doi:10.5604/17331331.1197327

Cited by 2 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Minea et al. () reported antimicrobial susceptibility of clinical isolates, largely confirming previous data. A Tunisian study (Eddouzi et al., ) reported high antimycotic susceptibility in clinical isolates of L. jadinii .…”

Section: Assessmentsupporting

confidence: 76%

“…Minea et al. () found L. jadinii in low prevalence from HIV or diabetes patients in Romania, but it the identification methods used in the study were not described. Hammad et al.…”

Section: Assessmentmentioning

confidence: 96%

“…In the majority of the publications, physiological criteria were used or the methodologies used were not specified. Using this approach, the presence of D. hansenii has been described in patients infected by HIV (Nidhi et al., ; Ribeiro et al., ; Minea et al., ), with cancer (Li et al., ; Nidhi et al., ), with post‐operational acute respiratory distress syndrome (Mun et al., ), with invasive candidiasis (Ghahri et al., ; Wang et al., ; Jung et al., ; Nieto et al., ), in pregnant women in Malaysia hospital (Masri et al., ) or vulvovaginal candidiasis (Liu et al., ), in patients with fungal eye infections (Ghodasra et al., ), with psoriasis (Sarvtin et al., ), with chronic diarrhoea (Banerjee et al., ), athlete′s foot (Chan et al., ) and in children with neutropenia (Haddadi et al., ). The value of these reports is often limited considering the limitations of the identification method.…”

Section: Assessmentmentioning

confidence: 99%

See 2 more Smart Citations

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

Ricci¹,

Allende²,

Bolton³

et al. 2017

EFS2

218

133

View full text Add to dashboard Cite

EFSA is requested to assess the safety of a broad range of biological agents in the context of notification for market authorisation as sources of food and feed additives, food enzymes and plant protection products. The qualified presumption of safety (QPS) assessment was developed to provide a harmonised generic preassessment to support safety risk assessments performed by EFSA's scientific Panels. The safety of unambiguously defined biological agents (at the highest taxonomic unit appropriate for the purpose for which an application is intended), and the completeness of the body of knowledge are assessed. Identified safety concerns for a taxonomic unit are, where possible and reasonable in number, reflected as 'qualifications' in connection with a recommendation for a QPS status. The list of QPS recommended biological agents was reviewed and updated in the current opinion and therefore becomes the valid list. The 2016 update reviews previously assessed microorganisms including bacteria, yeasts and viruses used for plant protection purposes following an Extensive Literature Search strategy. The taxonomic units related to the new notifications received since the 2013 QPS opinion, were periodically evaluated for a QPS status and the results published as Statements of the BIOHAZ Panel. Carnobacterium divergens, Lactobacillus diolivorans, Microbacterium imperiale, Pasteuria nishizawae, Pediococcus parvulus, Bacillus flexus, Bacillus smithii, Xanthomonas campestris and Candida cylindracea were recommended for the QPS list. All taxonomic units previously recommended for the 2013 QPS list had their status reconfirmed as well their qualifications with the exception of Pasteuria nishizawae for which the qualification was removed. The exclusion of filamentous fungi and enterococci from the QPS evaluations was reconsidered but monitoring will be maintained and the status will be re-evaluated in the next QPS Opinion update. Evaluation of bacteriophages should remain as a case-by-case procedure and should not be considered for QPS status. Acknowledgements: The BIOHAZ Panel wishes to thank the EFSA staff member: Mirena Ivanova for the support provided to this scientific output.

show abstract

Section: Assessmentsupporting

confidence: 76%

“…Minea et al. () found L. jadinii in low prevalence from HIV or diabetes patients in Romania, but it the identification methods used in the study were not described. Hammad et al.…”

Section: Assessmentmentioning

confidence: 96%

Section: Assessmentmentioning

confidence: 99%

See 1 more Smart Citation

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

Ricci¹,

Allende²,

Bolton³

et al. 2017

EFS2

218

133

View full text Add to dashboard Cite

show abstract

Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China

Yu¹,

Zhang²,

Chen³

et al. 2019

IDR

View full text Add to dashboard Cite

Introduction: We studied the species distribution and antifungal susceptibilities of Candida isolates causing refractory or recurrent oropharyngeal candidiasis (OPC) in a multicenter study in China (2013–2016). Methods: Species identification was performed using the Bruker Biotyper (Bruker Daltonics, Germany) matrix-assisted laser desorption/ionization time of flight mass spectrometry system supplemented by internal transcribed spacer sequencing as required. Antifungal susceptibilities were determined by the Clinical and Laboratory Standards Institute document (CLSI) M27-A3 broth microdilution methodology. Results: A total of 558 non-duplicate Candida isolates comprising 10 species were obtained from 535 patients. Candida albicans was the most common species (89.6%), followed by C. glabrata (5.2%), C. tropicalis (2.9%), and C. parapsilosis (0.7%). Azoles were active against C. albicans with susceptibility rates of 96% and 95.8% for fluconazole and voriconazole, respectively. MIC 50 values of C. albicans to fluconazole, voriconazole, itraconazole, and miconazole were 1, 0.03, 0.25 and 0.12 μg/mL, respectively, higher than those in previous studies of which OPC patients (corresponding MIC 50 values of 0.25 , 0.015 , 0.06 , and 0.03 μg/mL). Except for itraconazole, the MIC 50 and MIC 90 values of 58 non- C. albicans to other azoles were two to threefold higher than C. albicans . Miconazole, amphotericin B, nystatin, and 5-ﬂucytosine had good in vitro antifungal activity for all isolates. Conclusion: The study provides valuable data on the species distribution and antifungal susceptibility of oropharyngeal Candida isolates from geographically diverse areas of China. C. albicans remains the most common species but with increasing rates of azoles resistance.

show abstract

Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus

Cited by 2 publications

References 27 publications

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

Scientific Opinion on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA†

<p><em>Candida</em> isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China</p>

Contact Info

Product

Resources

About